HUMAN BIOSENSORS FOR DETECTING VOLTAGE CHANGES
    4.
    发明申请
    HUMAN BIOSENSORS FOR DETECTING VOLTAGE CHANGES 审中-公开
    用于检测电压变化的人体感应器

    公开(公告)号:US20170016912A1

    公开(公告)日:2017-01-19

    申请号:US15263182

    申请日:2016-09-12

    发明人: Angela Huang

    摘要: This invention provides biosensors, cell models, and methods of their use for monitoring heme, oxygen or ATP. Biosensors can include targeting domains, sensing domains and reporting domains. Biosensors can be introduced into cells reprogrammed to represent experimental or pathologic cells of interest. Model cells expressing the biosensors can be contacted with putative bioactive agents to determine possible activities.

    摘要翻译: 本发明提供生物传感器,细胞模型及其用于监测血红素,氧或ATP的方法。 生物传感器可以包括定位域,感知域和报告域。 可以将生物传感器引入重新编程以代表感兴趣的实验或病理细胞的细胞中。 可以将表达生物传感器的模型细胞与推定的生物活性剂接触以确定可能的活性。

    Human biosensors for detecting voltage changes
    5.
    发明授权
    Human biosensors for detecting voltage changes 有权
    用于检测电压变化的人体生物传感器

    公开(公告)号:US09528999B1

    公开(公告)日:2016-12-27

    申请号:US15263182

    申请日:2016-09-12

    发明人: Angela Huang

    摘要: This invention provides biosensors, cell models, and methods of their use for monitoring heme, oxygen or ATP. Biosensors can include targeting domains, sensing domains and reporting domains. Biosensors can be introduced into cells reprogrammed to represent experimental or pathologic cells of interest. Model cells expressing the biosensors can be contacted with putative bioactive agents to determine possible activities.

    摘要翻译: 本发明提供生物传感器,细胞模型及其用于监测血红素,氧或ATP的方法。 生物传感器可以包括定位域,感知域和报告域。 可以将生物传感器引入重新编程以代表感兴趣的实验或病理细胞的细胞中。 可以将表达生物传感器的模型细胞与推定的生物活性剂接触以确定可能的活性。

    Importation of mitochondrial protein by an enhanced allotopic approach
    6.
    发明授权
    Importation of mitochondrial protein by an enhanced allotopic approach 有权
    通过增强的同位素方法进入线粒体蛋白

    公开(公告)号:US09017999B2

    公开(公告)日:2015-04-28

    申请号:US11913618

    申请日:2006-05-03

    摘要: The inventors demonstrate that mRNA sorting to the mitochondrial surface is an efficient way to proceed to such an allotopic expression, and that this mRNA sorting can be controlled by selecting appropriate mitochondrion-targeting sequence (MTS) and appropriate 3′UTR sequences. The CDS sequence which codes for the protein to be delivered into the mitochondrion is guided by these appropriate MTS and 3′UTR sequences from the nuclear compartment to the mitochondrion-bound polysomes (where the CDS is translated), and aids in an efficient translocation of a mature functional protein into the mitochondria. Appropriate MTS and 3′UTR sequences correspond to those of nuclearly-transcribed mitochondrially-targeted mRNAs. The inventors demonstrate that, to obtain a stable therapeutically-effective importation, both an appropriate MTS and an appropriate 3′UTR should preferably be used.

    摘要翻译: 本发明人证明,对线粒体表面的mRNA分选是进行这种同种异体表达的有效方式,并且可以通过选择适当的线粒体靶向序列(MTS)和合适的3'UTR序列来控制该mRNA分选。 编码要递送到线粒体中的蛋白质的CDS序列由这些适当的MTS和3'UTR序列从核隔室引导到线粒体结合的多核糖体(其中CDS被翻译),并且有助于有效移位 成熟的功能蛋白进入线粒体。 适当的MTS和3'UTR序列对应于核转录的线粒体靶向mRNA的那些。 发明人证明,为了获得稳定的治疗有效的进口,优选使用适当的MTS和适当的3'UTR。